AAAAAA

   
Results: 1-8 |
Results: 8
Creatininemia during fibrate therapy: a reply to Lipscombe et al.
Authors: Hottelart, C Achard, JM Fournier, A
Citation: C. Hottelart et al., Creatininemia during fibrate therapy: a reply to Lipscombe et al., CLIN NEPHR, 56(1), 2001, pp. 85-86
Renal osteodystrophy (2): its treatment before dialysis.
Authors: Hottelart, C Bako, G Oprisiu, R Georgita, A Presne, C Sarraj, A Moriniere, P El Esper, N Fournier, A
Citation: C. Hottelart et al., Renal osteodystrophy (2): its treatment before dialysis., NEPHROLOGIE, 21(6), 2000, pp. 275-282
Renal osteodystrophy: invasive versus non invasive diagnosis of its pathological varieties
Authors: Oprisiu, R Hottelart, C Ghitsu, S Said, S Westeel, PF Moriniere, P El Esper, N Pruna, A Fournier, A
Citation: R. Oprisiu et al., Renal osteodystrophy: invasive versus non invasive diagnosis of its pathological varieties, NEPHROLOGIE, 21(5), 2000, pp. 229-237
Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation
Authors: Westeel, FP Mazouz, H Ezaitouni, F Hottelart, C Ivan, C Fardellone, P Brazier, M El Esper, I Petit, J Achard, JM Pruna, A Fournier, A
Citation: Fp. Westeel et al., Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation, KIDNEY INT, 58(4), 2000, pp. 1788-1796
Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients
Authors: Fournier, A Ghitu, S Bako, G Ben Amar, L Oprisiu, R Hottelart, C Solal, MEC
Citation: A. Fournier et al., Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients, NEPH DIAL T, 14(11), 1999, pp. 2772-2773
Prevention of stroke and cancer - Could angiotensin II type 1 receptor antagonists do better than angiotensin II converting enzyme inhibitors?
Authors: Achard, JM Pruna, A Fernandez, LA Hottelart, C Mazouz, H Rosa, A Andrejak, M Fournier, A
Citation: Jm. Achard et al., Prevention of stroke and cancer - Could angiotensin II type 1 receptor antagonists do better than angiotensin II converting enzyme inhibitors?, AM J HYPERT, 12(10), 1999, pp. 1050-1053
Fenofibrate increases creatininemia but does not alter glomerular filtration rate in patients with mild renal insufficiency
Authors: Hottelart, C El Esper, N Achard, JM Pruna, A Fournier, A
Citation: C. Hottelart et al., Fenofibrate increases creatininemia but does not alter glomerular filtration rate in patients with mild renal insufficiency, NEPHROLOGIE, 20(1), 1999, pp. 41-44
Could angiotensin II type I receptor antagonists (ARAT1) better prevent stroke than angiotensin II converting enzyme inhibitors (ACEI)?
Authors: Fournier, A Achard, JM Mazouz, H Pruna, A Hottelart, C Rosa, A Fernandez, L Andrejak, M
Citation: A. Fournier et al., Could angiotensin II type I receptor antagonists (ARAT1) better prevent stroke than angiotensin II converting enzyme inhibitors (ACEI)?, ARCH MAL C, 92(8), 1999, pp. 997-1000
Risultati: 1-8 |